Lupus Infusion Treatment
AmeriPharma® Specialty Care provides expert infusion therapy for patients with systemic lupus erythematosus (SLE) and lupus nephritis, offering personalized biologic care, insurance coordination, and clinical monitoring to support long-term disease management.
When Is Infusion Therapy Recommended for Lupus?
Infusion therapy may be recommended for patients with lupus when standard oral medications are not enough to adequately control symptoms or prevent disease progression. This is particularly true for individuals with moderate-to-severe systemic lupus erythematosus (SLE) or those with active lupus nephritis, where more targeted treatment is needed to reduce inflammation and protect vital organs.
Patients who may benefit from infusion therapy include:
- Individuals with a confirmed diagnosis of SLE or lupus nephritis
- Patients with moderate-to-severe disease activity that is not well controlled with conventional treatments such as hydroxychloroquine, corticosteroids, or immunosuppressants
- Those who experience frequent or severe lupus flares despite ongoing therapy
- Patients with active lupus nephritis who require biologic therapies to help preserve kidney function
- Individuals who need intravenous (IV) pulse corticosteroids to quickly manage acute, severe flares
Infusion therapy allows for the delivery of advanced biologic medications and high-dose treatments in a controlled clinical setting, helping to better manage complex or refractory lupus cases.
FDA-Approved Infusion Therapies for Lupus
Gazyva® (obinutuzumab) — For Lupus Nephritis
Gazyva® (obinutuzumab) is an FDA-approved infusion therapy for adults with active lupus nephritis who are receiving standard treatment, including mycophenolate mofetil and corticosteroids. Approved in October 2025, it represents one of the few targeted therapies specifically indicated for lupus nephritis.
Obinutuzumab is a CD20-directed monoclonal antibody that works by targeting and depleting B cells, which play a key role in driving the autoimmune inflammation associated with lupus. By reducing these disease-causing cells, Gazyva® helps control kidney inflammation and may help prevent or delay progression to advanced kidney disease.
The medication is administered intravenously on a structured schedule: an initial 1,000 mg infusion, followed by a second dose at week 2, then additional doses at weeks 24 and 26, and every 6 months thereafter. After the first infusion, eligible patients may receive subsequent infusions over a shorter duration of approximately 90 minutes.
IV Corticosteroids (Pulse Therapy)
Intravenous (IV) corticosteroids, such as methylprednisolone, are commonly used as pulse therapy to quickly control severe lupus flares or rapidly reduce inflammation in active lupus nephritis.
These high-dose treatments are typically given over a short period to stabilize the condition and prevent further organ damage. IV corticosteroids are generally used as part of an overall treatment plan and are not intended for long-term use on their own due to potential side effects.
IVIG (Off-Label)
Intravenous immunoglobulin (IVIG) may be considered in select cases of lupus, particularly when the disease is refractory to standard treatments, in severe lupus nephritis, or when certain hematologic complications are present.
Although not specifically FDA-approved for lupus, IVIG is used off-label to help regulate the immune system. It works by providing a concentrated pool of normal antibodies that can help counteract the abnormal autoimmune activity seen in lupus, supporting better disease control in complex cases.
Get Lupus Infusion Care With AmeriPharma® Specialty Care
Proactive, Personalized Lupus Care
- 指派专职临床医生负责您的护理。
- Ongoing monitoring and treatment adjustments in coordination with your healthcare team including your rheumatologist, pharmacist, and infusion nurse
- Care team communication across your full treatment timeline
专家临床团队
- Clinical pharmacists specializing in biologic and immunotherapy treatments
- Experienced infusion nurses trained in lupus-specific protocols
- Patient care coordinators manage scheduling and refills
舒适的门诊环境和灵活的预约时间
- Private, calm infusion suites — not a hospital environment
- Flexible appointment times, including evenings and weekends where available
- 为您提供有助于您在治疗期间放松的设施
- Option to have it done in the comfort of your home
保险支持和财务援助
- 完整的保险核实和预先授权处理
- Medicare 和大多数主要私人保险计划均可接受
- 为符合条件的患者提供经济援助计划
- 治疗开始前需明确列出所有自付费用明细
How Does Lupus Infusion Treatment Work?
-
第一步：保险核实和事先授权
Your care begins with AmeriPharma’s team handling insurance verification and prior authorization paperwork. We coordinate with your prescribing rheumatologist to ensure a smooth approval process, typically completed within a few days.
-
第二步：预约
Once approved, we schedule your infusion at a time that works for you. Flexible scheduling options — including evenings and weekends where available — help minimize disruption to your daily life.
-
第三步：舒适的输液体验
During your appointment, a healthcare professional places a small IV and monitors your vital signs throughout treatment. Infusion duration varies by medication — from 30 minutes to a few hours. You can relax, read, watch TV, or use your devices during treatment.
-
第四步：持续监测和临床支持
Our clinical staff monitors for any reactions and provides post-infusion support. Follow-up infusions are scheduled based on your treatment protocol, and our care team stays in communication with your rheumatologist to track your progress.
评价
服务区域
AmeriPharma’s lupus infusion services are available in multiple states throughout the US. We are fully licensed and able to extend our services in the areas marked in blue on the map.
Frequently Asked Questions About Lupus Infusion Treatment
How long does a lupus infusion take?
The length of a lupus infusion depends on the medication being administered. Initial infusions may take several hours to ensure safety and monitor for reactions Subsequent infusions can be adjusted as necessary based on the patient’s response.
How do I know which infusion therapy is right for me?
The right infusion therapy is determined by your healthcare provider based on your diagnosis, disease severity, treatment history, and overall health. They will evaluate your response to current medications and recommend an option that best fits your clinical needs.
What should I expect during my first infusion appointment?
During your first infusion, a trained clinician will start an IV line and closely monitor you throughout the treatment. The appointment may take longer than future visits to ensure you tolerate the medication well. You can expect a comfortable setting, regular vital sign checks, and support from clinical staff.
Can I continue my other lupus medications while receiving infusion therapy?
In many cases, patients continue certain lupus medications, such as immunosuppressants or corticosteroids, alongside infusion therapy. Your provider will determine the appropriate combination based on your treatment plan.
Will I need lupus infusions indefinitely?
Not necessarily. The duration of infusion therapy varies depending on how well your lupus is controlled and how you respond to treatment. Some patients may require ongoing therapy, while others may transition to different treatments over time.
Does AmeriPharma offer home infusion for lupus?
Yes. AmeriPharma Specialty Care offers home infusion services for select lupus therapies when appropriate. Eligible patients can receive treatment in the comfort of their home under the supervision of experienced infusion nurses.
Start Your Lupus Infusion Care Today
AmeriPharma® Specialty Care provides personalized lupus infusion therapy with expert clinical support, insurance coordination, and a comfortable outpatient experience. 立即开始 with a trusted specialty pharmacy that makes managing lupus easier.
资源
-
静脉注射免疫球蛋白（IVIG）治疗系统性红斑狼疮
About 1.5 million Americans are living with lupus, with an…
-
类风湿关节炎与狼疮：相似之处和不同之处
Rheumatoid arthritis and lupus are two autoimmune disorders that affect…
-
红斑狼疮患者的预期寿命：最新研究结果（以及如何提高您的预期寿命）
If you or someone you love has been diagnosed with…
-
狼疮 IVIG 治疗指南
Lupus is a chronic autoimmune condition affecting millions of people…